In a preclinical setting, a lethal form of ovarian cancer is cured by nuclear medicine treatment.

Published Date: 20 Sep 2023

In a preclinical setting, it has been demonstrated that a new 225Ac-DOTA-based pre-targeted radioimmunotherapy (PRIT) system can effectively treat an advanced intraperitoneal cancer that is highly lethal with only minor side effects. the. as a target.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Targeted radiation therapy shows near-complete response in rare sarcoma patients

2.

Dostarlimab Boosts Long-Term Survival in Endometrial Cancer

3.

Germline Profiling May Improve Risk Stratification in t-MNs

4.

Results for Prostate Cancer Are Associated With PSA Nadir 6 Months After Primary RT.

5.

Scientists call into question safety of potential new anticancer treatment


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot